平安好醫生(01833.HK)推「名醫工作室」提供細分專科服務
平安好醫生(01833.HK)公布,繼多家互聯網醫院落地、多地醫保在線支付打通之後,集團在互聯網醫療服務領域持續發力,與眾多專病領域學者和國家重點學科帶頭人、名醫等聯手推出互聯網醫療服務新模式「名醫工作室」,為患者提供優質的醫療服務。目前「名醫工作室」已經涵蓋皮膚科、兒科、婦產科、泌尿外科、骨科、中醫科等細分專科。
集團指,「名醫工作室」貫穿診前、診中、診後全流程,全國專家名醫進行在線問診,聚焦專科專病,為患者提供專家診療方案。平安好醫生的全職醫生通過名醫認證後幫助名醫完成診前準備、診後回訪等工作。
於8月27日,上海中醫藥大學附屬曙光醫院中醫內科主任醫師蔣健教授、同濟大學附屬東方醫院心臟內科常務副主任張奇教授等多位名醫與平安好醫生簽約,成為第二批平安好醫生名醫合夥人,未來將有更多醫學專家加入名醫工作室並投入運營。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.